A four-component, one-pot procedure gives access to alpha-functionalized imidates starting from readily available terminal alkynes, sulfonyl azides, alcohols and nitroalkenes using a copper catalyst and triethylamine as a base under mild conditions.
No takes yet. Share an insight, caveat, or question.
Husmann et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: